During 1989, Livzon blew a whirlwind of "Livzon is very happy" all over the country, and men need more care. A affectionate word made Livzon enter thousands of households, and Livzon became one of the top 500 industrial enterprises in China.

1993 "000513" and "200513" became the code names of Livzon in Chinese mainland and Hongkong. Livzon is the first company in China pharmaceutical industry to list and trade A and B shares.

From 65438 to 0995, Livzon entered the top 50 pharmaceutical industries in China.

65438-0996 Livzon was ranked as one of the 520 key enterprises in China by the State Economic and Trade Commission and the People's Bank of China, and was recognized as one of the 76 key high-tech enterprises (groups) in the National Torch Program by the State Science and Technology Commission.

From 65438 to 0998, Livzon was awarded the "Torch Excellent Enterprise Award" by the State and Guangdong Province.

1999 The registered trademark of Livzon was recognized as a well-known trademark in China by the State Administration for Industry and Commerce.

In 2000, Livzon became one of the 50 leading enterprises in Guangdong Province.

In 200 1 year, the National Research Center for Modernization Engineering and Technology of Traditional Chinese Medicine was built and put into use in Livzon.

In 2002, Taitai Pharmaceutical became the largest shareholder of Livzon, realizing the "strong alliance" of China pharmaceutical industry.

Historical witness Livzon 18 bears the wind and rain, and digitally writes the five flavors of Livzon in the Spring and Autumn Period. In 18, Livzon's assets increased by more than 400 times from 5 million to more than 2 billion. In 18, Livzon's shareholders received more than 50 times returns, with an average annual return of nearly 30%. In 18, Livzon changed from a small workshop with a tin house to a 2 1 wholly-owned, holding and joint venture China large-scale pharmaceutical group company integrating product development, production and sales. More than 4,000 employees, the most professional sales team in China pharmaceutical industry, lead the country in the three dominant fields of digestive tract drugs, cardiovascular and cerebrovascular drugs and anti-infective drugs. There are 54 national new products, 8 national and provincial "Torch" projects and 2 national 863 key projects, and they have won the Zhuhai Science and Technology Progress Special Award with great influence in China for four consecutive times, 29 production lines have passed GMP certification and 2 enterprises have passed GSP certification.